Journal
PHARMACEUTICALS
Volume 14, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/ph14020118
Keywords
clozapine; mood stabilizer; refractory psychosis; pharmacogenomics; predictive model; methylome; polygenic risk scores
Categories
Funding
- CONACyT [233695]
Ask authors/readers for more resources
This study investigated the mechanisms of action of Clozapine in patients with refractory psychosis, revealing an association between bipolar disorder risk score and Clozapine metabolic ratio, particularly in the GABAergic synapse pathway. The findings support the potential use of Clozapine as a mood stabilizer in addition to its antipsychotic effects, highlighting the need for further research with larger sample sizes to confirm these results.
Clozapine (CLZ) is the only antipsychotic drug that has been proven to be effective in patients with refractory psychosis, but it has also been proposed as an effective mood stabilizer; however, the complex mechanisms of action of CLZ are not yet fully known. To find predictors of CLZ-associated phenotypes (i.e., the metabolic ratio, dosage, and response), we explore the genomic and epigenomic characteristics of 44 patients with refractory psychosis who receive CLZ treatment based on the integration of polygenic risk score (PRS) analyses in simultaneous methylome profiles. Surprisingly, the PRS for bipolar disorder (BD-PRS) was associated with the CLZ metabolic ratio (pseudo-R-2 = 0.2080, adjusted p-value = 0.0189). To better explain our findings in a biological context, we assess the protein-protein interactions between gene products with high impact variants in the top enriched pathways and those exhibiting differentially methylated sites. The GABAergic synapse pathway was found to be enriched in BD-PRS and was associated with the CLZ metabolic ratio. Such interplay supports the use of CLZ as a mood stabilizer and not just as an antipsychotic. Future studies with larger sample sizes should be pursued to confirm the findings of this study.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available